{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:39:06Z","timestamp":1779377946657,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["16K08544"],"award-info":[{"award-number":["16K08544"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20K06553"],"award-info":[{"award-number":["20K06553"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19H03499"],"award-info":[{"award-number":["19H03499"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aggressive invasiveness of malignant mesothelioma limits cancer therapy, however, the molecular mechanisms underlying the invasiveness remain largely unknown. Here we found that the matrix metalloproteinase-2 (MMP-2) was required for the invasion of mesothelioma cells in the collagen matrix and the gene expression of MMP-2 was correlated with the invasive phenotype. The MMP-2 gene expression was regulated by DNA and histone methylation around the transcription start site, implicating the involvement of the polycomb repressive complex (PRC). Knockdown of PRC component chromobox 6 (CBX6) promoted MMP-2 expression and invasion of mesothelioma cells. Transcriptome analysis suggested that CBX6 regulates sets of genes involved in cancer cell migration and metastasis. In invasive but not non-invasive cells, CBX6 was constantly unstable owing to ubiquitination and protein degradation. In human tissues, CBX6 localized in the nuclei of normal mesothelium and benign mesothelioma, but the nuclear staining of CBX6 was lost in malignant mesothelioma. These results suggest involvement of proteasomal degradation of CBX6 in mesothelioma progression.<\/jats:p>","DOI":"10.1038\/s41598-020-72448-y","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T10:02:46Z","timestamp":1602064966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-1786","authenticated-orcid":false,"given":"Katsuya","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9429-5396","authenticated-orcid":false,"given":"Takumi","family":"Nishiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-6938","authenticated-orcid":false,"given":"Shoichiro","family":"Tange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-2988","authenticated-orcid":false,"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5688-5181","authenticated-orcid":false,"given":"Minoru","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-4482","authenticated-orcid":false,"given":"Kunio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"72448_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jtho.2015.10.012","volume":"11","author":"L Mutti","year":"2016","unstructured":"Mutti, L. et al. Scientific advances and new frontiers in mesothelioma therapeutics. J. Thorac. Oncol. 11, 8 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"72448_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/jdb7020007","volume":"7","author":"E Hiriart","year":"2019","unstructured":"Hiriart, E., Deepe, R. & Wessels, A. Mesothelium and malignant mesothelioma. J. Dev. Biol. 7, 7 (2019).","journal-title":"J. Dev. Biol."},{"key":"72448_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ht7030020","volume":"7","author":"AP Sage","year":"2018","unstructured":"Sage, A. P. et al. Genomics and epigenetics of malignant mesothelioma. High-Throughput 7, 20 (2018).","journal-title":"High-Throughput"},{"key":"72448_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","volume":"278","author":"C Gialeli","year":"2011","unstructured":"Gialeli, C., Theocharis, A. D. & Karamanos, N. K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278, 16\u201327 (2011).","journal-title":"FEBS J."},{"key":"72448_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","unstructured":"Jab\u0142o\u0144ska-Trypu\u0107, A., Matejczyk, M. & Rosochacki, S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J. Enzyme Inhib. Med. Chem. 31, 177\u2013183 (2016).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"72448_CR6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1083\/jcb.149.6.1309","volume":"149","author":"K Hotary","year":"2000","unstructured":"Hotary, K., Allen, E., Punturieri, A., Yana, I. & Weiss, S. J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell. Biol. 149, 1309\u20131323 (2000).","journal-title":"J. Cell. Biol."},{"key":"72448_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/sj.bjc.6600920","volume":"88","author":"JG Edwards","year":"2003","unstructured":"Edwards, J. G., McLaren, J., Jones, J. L., Waller, D. A. & O\u2019Byrne, K. J. Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. Br. J. Cancer 88, 1553\u20131559 (2003).","journal-title":"Br. J. Cancer"},{"key":"72448_CR8","first-page":"1283","volume":"22","author":"MW Roomi","year":"2009","unstructured":"Roomi, M. W., Monterrey, J. C., Kalinovsky, T., Niedzwiecki, A. & Rath, M. Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines. Oncol. Rep. 22, 1283\u20131291 (2009).","journal-title":"Oncol. Rep."},{"key":"72448_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yexmp.2010.10.008","volume":"90","author":"T Doi","year":"2011","unstructured":"Doi, T. et al. MT1-MMP plays an important role in an invasive activity of malignant pleural mesothelioma cell. Exp. Mol. Pathol. 90, 91\u201396 (2011).","journal-title":"Exp. Mol. Pathol."},{"key":"72448_CR10","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.1074\/jbc.M900273200","volume":"284","author":"AV Chernov","year":"2009","unstructured":"Chernov, A. V., Sounni, N. E., Remacle, A. G. & Strongin, A. Y. Epigenetic control of the invasion-promoting MT1-MMP\/MMP-2\/TIMP-2 axis in cancer cells. J. Biol. Chem. 284, 12727\u201312734 (2009).","journal-title":"J. Biol. Chem."},{"key":"72448_CR11","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3892\/ijo.2014.2646","volume":"45","author":"SA Yi","year":"2014","unstructured":"Yi, S. A., Ryu, H. W., Lee, D. H., Han, J. W. & Kwon, S. H. HP1\u03b2 suppresses metastasis of human cancer cells by decreasing the expression and activation of MMP2. Int. J. Oncol. 45, 2541\u20132548 (2014).","journal-title":"Int. J. Oncol."},{"key":"72448_CR12","doi-asserted-by":"publisher","first-page":"e105806","DOI":"10.1371\/journal.pone.0105806","volume":"9","author":"IT Pereira","year":"2014","unstructured":"Pereira, I. T. et al. Fibronectin affects transient MMP2 gene expression through DNA demethylation changes in non-invasive breast cancer cell lines. PLoS ONE 9, e105806. https:\/\/doi.org\/10.1371\/journal.pone.0105806 (2014).","journal-title":"PLoS ONE"},{"key":"72448_CR13","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/ol.2015.3570","volume":"10","author":"YH Wang","year":"2015","unstructured":"Wang, Y. H. et al. BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway. Oncol. Lett. 10, 2227\u20132232 (2015).","journal-title":"Oncol. Lett."},{"key":"72448_CR14","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.3892\/or.2016.4729","volume":"35","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion. Oncol. Rep. 35, 3586\u20133592 (2016).","journal-title":"Oncol. Rep."},{"key":"72448_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.tibs.2019.04.005","volume":"44","author":"HL Chan","year":"2019","unstructured":"Chan, H. L. & Morey, L. Emerging roles for polycomb-group proteins in stem cells and cancer. Trends Biochem. Sci. 44, 688\u2013700 (2019).","journal-title":"Trends Biochem. Sci."},{"key":"72448_CR16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1631\/jzus.B1400077","volume":"15","author":"RG Ma","year":"2014","unstructured":"Ma, R. G., Zhang, Y., Sun, T. T. & Cheng, B. Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins. J. Zhejiang Univ. Sci. B 15, 1567\u20131570 (2014).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"72448_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.stem.2011.12.006","volume":"10","author":"L Morey","year":"2012","unstructured":"Morey, L. et al. Nonoverlapping functions of the polycomb group Cbx family of proteins in embryonic stem cells. Cell Stem Cell 10, 47\u201362 (2012).","journal-title":"Cell Stem Cell"},{"key":"72448_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41467-017-01464-w","volume":"8","author":"A Santanach","year":"2017","unstructured":"Santanach, A. et al. The polycomb group protein CBX6 is an essential regulator of embryonic stem cell identity. Nat. Commun. 8, 1235 (2017).","journal-title":"Nat. Commun."},{"key":"72448_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/ncb2701","volume":"15","author":"K Klauke","year":"2013","unstructured":"Klauke, K. et al. Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation. Nat. Cell Biol. 15, 412\u2013428 (2013).","journal-title":"Nat. Cell Biol."},{"key":"72448_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41389-018-0103-1","volume":"7","author":"LJ Wheeler","year":"2018","unstructured":"Wheeler, L. J. et al. CBX2 identified as a driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis 7, 92 (2018).","journal-title":"Oncogenesis"},{"key":"72448_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41467-020-14870-4","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Targeting the CK1\u03b1\/CBX4 axis for metastasis in osteosarcoma. Nat. Commun. 11, 1141 (2020).","journal-title":"Nat. Commun."},{"key":"72448_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41598-018-36560-4","volume":"9","author":"H Deng","year":"2019","unstructured":"Deng, H. et al. CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer. Sci. Rep. 9, 197 (2019).","journal-title":"Sci. Rep."},{"key":"72448_CR23","doi-asserted-by":"publisher","first-page":"27753","DOI":"10.1038\/srep27753","volume":"6","author":"Z Nawaz","year":"2016","unstructured":"Nawaz, Z. et al. Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP\/TAZ-dependent transcription. Sci. Rep. 6, 27753 (2016).","journal-title":"Sci. Rep."},{"key":"72448_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill, F. Cancer and the chemokine network. Nat. Rev. Cancer 4, 540\u2013550 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"72448_CR25","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1093\/hmg\/ddn248","volume":"17","author":"S Nola","year":"2008","unstructured":"Nola, S. et al. Scrib regulates PAK activity during the cell migration process. Hum. Mol. Genet. 17, 3552\u20133565 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"72448_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12964-018-0312-4","volume":"16","author":"B Dai","year":"2018","unstructured":"Dai, B. et al. Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma. Cell Commun. Signal 16, 99 (2018).","journal-title":"Cell Commun. Signal"},{"key":"72448_CR27","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1074\/jbc.RA118.006122","volume":"294","author":"W Deng","year":"2019","unstructured":"Deng, W., Fernandez, A., McLaughlin, S. L. & Klinke, D. J. II. WNT1-inducible signaling pathway protein 1 (WISP1\/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial\u2013mesenchymal transition. J. Biol. Chem. 294, 5261\u20135280 (2019).","journal-title":"J. Biol. Chem."},{"key":"72448_CR28","doi-asserted-by":"publisher","unstructured":"Deng, W., Fernandez, A., McLaughlin, S. L. & Klinke, D.J. II. Cell Communication Network factor 4 (CCN4\/WISP1) shifts melanoma cells from a fragile proliferative state to a resilient metastatic state. bioRxiv (2019). https:\/\/doi.org\/10.1101\/487751","DOI":"10.1101\/487751"},{"key":"72448_CR29","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3892\/ol.2016.4929","volume":"12","author":"N Kindt","year":"2016","unstructured":"Kindt, N., Journe, F., Laurent, G. & Saussez, S. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncol. Lett. 12, 2247\u20132253 (2016).","journal-title":"Oncol. Lett."},{"key":"72448_CR30","first-page":"1313","volume":"55","author":"L Han","year":"2019","unstructured":"Han, L., Zan, Y., Huang, C. & Zhang, S. NELFE promoted pancreatic cancer metastasis and the epithelial-to-mesenchymal transition by decreasing the stabilization of NDRG2 mRNA. Int. J. Oncol. 55, 1313\u20131323 (2019).","journal-title":"Int. J. Oncol."},{"key":"72448_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ccell.2017.06.002","volume":"32","author":"H Dang","year":"2017","unstructured":"Dang, H. et al. Oncogenic activation of the RNA binding protein NELFE and MYC signaling in hepatocellular carcinoma. Cancer Cell 32, 101\u2013114 (2017).","journal-title":"Cancer Cell"},{"key":"72448_CR32","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1038\/onc.2017.63","volume":"36","author":"NLE Harris","year":"2017","unstructured":"Harris, N. L. E. et al. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. Oncogene 36, 4288\u20134298 (2017).","journal-title":"Oncogene"},{"key":"72448_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1677\/ERC-08-0079","volume":"15","author":"FRM Latini","year":"2008","unstructured":"Latini, F. R. M., Hemerly, J. P., Oler, G., Riggins, G. J. & Cerutti, J. M. Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. Endocr. Relat. Cancer 15, 787\u2013799 (2008).","journal-title":"Endocr. Relat. Cancer"},{"key":"72448_CR34","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2353\/ajpath.2006.050384","volume":"168","author":"K Ikeda","year":"2006","unstructured":"Ikeda, K. et al. Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am. J. Pathol. 168, 856\u2013865 (2006).","journal-title":"Am. J. Pathol."},{"key":"72448_CR35","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1111\/jcmm.13184","volume":"21","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3\/MMP2 signalling. J. Cell. Mol. Med. 21, 2685\u20132694 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"72448_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-019-1060-9","volume":"18","author":"J Bi","year":"2019","unstructured":"Bi, J. et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p\/p21 axis and acts as a prognostic factor of recurrence. Mol. Cancer 18, 133 (2019).","journal-title":"Mol. Cancer"},{"key":"72448_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","volume":"125","author":"BE Bernstein","year":"2006","unstructured":"Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315\u2013326 (2006).","journal-title":"Cell"},{"key":"72448_CR38","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.1021\/bi901131u","volume":"48","author":"I Bezsonova","year":"2009","unstructured":"Bezsonova, I. et al. Ring1B contains a ubiquitin-like docking module for interaction with Cbx proteins. Biochemistry 48, 10542\u201310548 (2009).","journal-title":"Biochemistry"},{"key":"72448_CR39","doi-asserted-by":"publisher","first-page":"e80970","DOI":"10.1371\/journal.pone.0080970","volume":"8","author":"G Li","year":"2013","unstructured":"Li, G. et al. Altered expression of polycomb group genes in glioblastoma multiforme. PLoS ONE 8, e80970 (2013).","journal-title":"PLoS ONE"},{"key":"72448_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41467-017-00301-4","volume":"8","author":"B Ning","year":"2017","unstructured":"Ning, B. et al. USP26 functions as a negative regulator of cellular reprogramming by stabilizing PRC1 complex components. Nat. Commun. 8, 349 (2017).","journal-title":"Nat. Commun."},{"key":"72448_CR41","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1021\/pr0705441","volume":"7","author":"GT Cantin","year":"2008","unstructured":"Cantin, G. T. et al. Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J. Proteome Res. 7, 1346\u20131351 (2008).","journal-title":"J. Proteome Res."},{"key":"72448_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1247\/csf.07035","volume":"33","author":"H Kimura","year":"2008","unstructured":"Kimura, H., Hayashi-Takanaka, Y., Goto, Y., Takizawa, N. & Nozaki, N. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct. Funct. 33, 61\u201373 (2008).","journal-title":"Cell Struct. Funct."},{"key":"72448_CR43","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/ijc.25197","volume":"127","author":"Y Suzuki","year":"2010","unstructured":"Suzuki, Y. et al. Inhibition of Met\/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma. Int. J. Cancer 127, 1948\u20131957 (2010).","journal-title":"Int. J. Cancer"},{"key":"72448_CR44","doi-asserted-by":"publisher","first-page":"47785","DOI":"10.1074\/jbc.M309482200","volume":"278","author":"X Han","year":"2003","unstructured":"Han, X., Boyd, P. J., Colgan, S., Madri, J. A. & Haas, T. L. Transcriptional up-regulation of endothelial cell matrix metalloproteinase-2 in response to extracellular cues involves GATA-2. J. Biol. Chem. 278, 47785\u201347791 (2003).","journal-title":"J. Biol. Chem."},{"key":"72448_CR45","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1158\/0008-5472.CAN-04-4570","volume":"65","author":"J Choi","year":"2005","unstructured":"Choi, J. et al. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res. 65, 5554\u20135560 (2005).","journal-title":"Cancer Res."},{"key":"72448_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1042\/BJ20110343","volume":"437","author":"M Yoshida","year":"2011","unstructured":"Yoshida, M. et al. PLU1 histone demethylase decreases the expression of KAT5 and enhances the invasive activity of the cells. Biochem. J. 437, 555\u2013564 (2011).","journal-title":"Biochem. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72448-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72448-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72448-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:42:09Z","timestamp":1670359329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72448-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72448"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72448-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"8 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16678"}}